Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Despite the existence of various therapeutic options, NSCLC is still a major health concern due to its aggressive nature and high mutation rate. Consequently, HER3 has been selected as a target protein along with EGFR because...

Descripción completa

Detalles Bibliográficos
Autores principales: Dera, Ayed A., Zaib, Sumera, Areeba, Hussain, Nadia, Rana, Nehal, Javed, Hira, Khan, Imtiaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304665/
https://www.ncbi.nlm.nih.gov/pubmed/37375404
http://dx.doi.org/10.3390/molecules28124850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304665/
https://www.ncbi.nlm.nih.gov/pubmed/37375404
http://dx.doi.org/10.3390/molecules28124850

Ejemplares similares